Motzer, R. J. et al. Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade. Cancer Cell 38, 803–817.e4 (2020).
Article CAS PubMed PubMed Central Google Scholar
Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers 3, 17009 (2017).
Article PubMed PubMed Central Google Scholar
Borràs, D. M. et al. Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer. Cell Discov. 9, 114 (2023).
Article PubMed PubMed Central Google Scholar
Sprooten, J. et al. Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer. J. Immunother. Cancer 9, e003609 (2021).
Article PubMed PubMed Central Google Scholar
Naulaerts, S. et al. Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer. Sci. Transl. Med. 15, eadd1016 (2023).
Article CAS PubMed Google Scholar
de Velasco, G. et al. Tumor mutational load and immune parameters across metastatic renal cell carcinoma risk groups. Cancer Immunol. Res. 4, 820–822 (2016).
Article PubMed PubMed Central Google Scholar
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
Article CAS PubMed PubMed Central Google Scholar
Fridman, W. H., Zitvogel, L., Sautès-Fridman, C. & Kroemer, G. The immune contexture in cancer prognosis and treatment. Nat. Rev. Clin. Oncol. 14, 717–734 (2017).
Article CAS PubMed Google Scholar
Ross-Macdonald, P. et al. Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. J. Immunother. Cancer 9, e001506 (2021).
Article PubMed PubMed Central Google Scholar
Cristescu, R. et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362, eaar3593 (2018).
Article PubMed PubMed Central Google Scholar
Au, L. et al. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell 39, 1497–1518.e11 (2021).
Article CAS PubMed PubMed Central Google Scholar
Braun, D. A. et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat. Med. 26, 909–918 (2020).
Article CAS PubMed PubMed Central Google Scholar
Chevrier, S. et al. An immune atlas of clear cell renal cell carcinoma. Cell 169, 736–749.e18 (2017).
Article CAS PubMed PubMed Central Google Scholar
Braun, D. A. et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell 39, 632–648.e8 (2021).
Article CAS PubMed PubMed Central Google Scholar
Bi, K. et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39, 649–661.e5 (2021).
Article CAS PubMed PubMed Central Google Scholar
Abernethy, A. Time for real-world health data to become routine. Nat. Med. 29, 1317 (2023).
Article CAS PubMed Google Scholar
Motzer, R. J. et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N. Engl. J. Med. 373, 1803–1813 (2015).
Article CAS PubMed PubMed Central Google Scholar
Motzer, R. J. et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N. Engl. J. Med. 378, 1277–1290 (2018).
Article CAS PubMed PubMed Central Google Scholar
McDermott, D. F. et al. Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat. Med. 24, 749–757 (2018).
Article CAS PubMed PubMed Central Google Scholar
Motzer, R. J. et al. Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nat. Med. 26, 1733–1741 (2020).
Article CAS PubMed PubMed Central Google Scholar
Beuselinck, B. et al. Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysis. Clin. Genitourin. Cancer 12, e205–e214 (2014).
Blum, K. A. et al. Sarcomatoid renal cell carcinoma: biology, natural history and management. Nat. Rev. Urol. 17, 659–678 (2020).
Article CAS PubMed PubMed Central Google Scholar
Carretero-González, A. et al. The value of PD-L1 expression as predictive biomarker in metastatic renal cell carcinoma patients: a meta-analysis of randomized clinical trials. Cancers (Basel) 12, 1945 (2020).
Ernst, M. S. et al. Outcomes for International metastatic renal cell carcinoma database consortium prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma. Eur. Urol. 84, 109–116 (2023).
Article CAS PubMed Google Scholar
Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773–782 (2019).
Article CAS PubMed PubMed Central Google Scholar
Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812–830.e14 (2018).
Article CAS PubMed PubMed Central Google Scholar
Lee, C.-H. et al. High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab. Mol. Cancer Res. 19, 1510–1521 (2021).
Article CAS PubMed PubMed Central Google Scholar
Naranbhai, V. et al. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Lancet Oncol. 23, 172–184 (2022).
Article CAS PubMed Google Scholar
Manczinger, M. et al. Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity. Nat. Cancer 2, 950–961 (2021).
Article CAS PubMed Google Scholar
Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).
Article CAS PubMed Google Scholar
Li, S. et al. Bioinformatics and in vitro-based comprehensive analysis of EVI2A expression and its immunological and prognostic significance in Kidney Renal Clear Cell Carcinoma. Res. Sq. https://doi.org/10.21203/rs.3.rs-2917863/v1 (2023).
Article PubMed PubMed Central Google Scholar
Tan, Q., Liu, H., Xu, J., Mo, Y. & Dai, F. Integrated analysis of tumor-associated macrophage infiltration and prognosis in ovarian cancer. Aging (Albany NY) 13, 23210–23232 (2021).
Article CAS PubMed Google Scholar
Brumell, J. H. et al. Expression of the protein kinase C substrate pleckstrin in macrophages: association with phagosomal membranes. J. Immunol. 163, 3388–3395 (1999).
Article CAS PubMed Google Scholar
Zakrzewska, A. et al. Macrophage-specific gene functions in Spi1-directed innate immunity. Blood 116, e1–e11 (2010).
Article CAS PubMed Google Scholar
MacParland, S. A. et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat. Commun. 9, 4383 (2018).
Article PubMed PubMed Central Google Scholar
Ihim, S. A. et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front. Immunol. 13, 919973 (2022).
留言 (0)